CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a coronavirus vaccine, in …
Read More »
Text size Moderna’s headquarters in Cambridge, Massachusetts. Joseph Prezioso / AFP / Getty Images Moderna’s announcement of positive data about a Phase 1 trial of its Covid-19 vaccine in May was met with skepticism by some experts, who noted that the company had not included many details about the trial’s …
Read More »
According to information published online in a medical journal, an experimental COVID-19 vaccine made by Moderna was able to induce an immune response in all volunteers in an early-stage trial. Initial results, published in The New England Journal of Medicine on Tuesday, showed that the vaccine was generally safe and …
Read More »
Moderna Inc.’s shares soared in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune system response in a larger group of people and the study will go on to a decisive clinical trial in July. Results published in The New England Journal …
Read More »
Operation Warp Speed is living up to its name as, according to the project, one of the leading candidates for the COVID-19 vaccine, AstraZeneca, is partnering with life science services company IQVIA to boost its work on the shot. Under the plan, the financial details of which were not disclosed, …
Read More »